Chris joined the Board of Oxford Research Group in September 2019. He has more than 30 years’ experience of global government affairs and public policy. He spent 22 years at GSK, the global pharmaceutical company, ending his career as Senior Vice-President, Government Affairs, and Special Adviser to the CEO and the Corporate Executive Team. Prior to GSK, Chris had roles as Managing Director of the government affairs consultancy Rowland Sallingbury Casey, and as Private Secretary to Ministers at the UK Department of Energy.

Since retiring from GSK in 2017, Chris has developed a portfolio of advisory and trustee roles to support public companies and not-for-profit organisations in managing issues with significant business, reputational or societal impact. These include pro-bono work with the All-Party Parliamentary Cycling Group.

Chris has served on company leadership teams, industry and government groups and committees, and think tanks. He has experience of very diverse issues, from core business/commercial (pricing, intellectual property, trade, tax) to macro and reputational (global health issues, compliance, ethical behaviours). He has a track record of working effectively with national governments, multilateral institutions, NGOs and CSOs, business groups, and other stakeholders. Chris  has a BA Hons in History from the University of Cambridge. He is married with one daughter. His interests and passions include cycling, politics,  music, theatre and Sunderland FC.